Skip to main content
Clinical Trials/NCT03877016
NCT03877016CompletedNot Applicable

Prospective, Multicentric, Randomized on Two Arms, Controlled, by Cross-over, Pilot Study, in Order to Evaluate Disconfort Among Outpatients Using actiTENS for Neuropathic Pain vs TENS ECO 2.

Centre Hospitalier Universitaire, Amiens5 sites in 1 country72 target enrollmentStarted: September 17, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
72
Locations
5
Primary Endpoint
Disconfort of using TENS (Electrical Nerve Stimulation Therapy) Eco2 versus actiTENS

Study Overview

Brief Summary

Non-pharmacological treatments for pain relief are more and more used in clinical care although any scientific validation. Among the non-pharmacological treatments of neuropathic pain relief, TENS (Electrical Nerve Stimulation Therapy) is the major treatment with the best benefit. Unfortunately, the use of TENS by patients appears very difficult. Because of this inconvenience, more than 40% of TENS users interrupt the treatment despite treatment benefit. A new TENS device: actiTENS that seems to be less constraining than TENS is now available in France. ActiTENS efficacy and safety compared to TENS need to be investigated.

The main objective is to evaluate and to compare the use of actiTENS, with TENS Eco 2, the classical device in patients with chronic neuropathic pain.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient covered by national health insurance
  • •Patient able to express consent
  • •Patient with neuropathic pain with DN4 (Douleur Neuropathique 4 Questions) > or = 4/
  • •Actual or potential neurologic lesion
  • •Patient still using a TENS device

Exclusion Criteria

  • •Planned surgery in the next two months
  • •Modification of the reatment in the next two motnhs
  • •Other study ongoing for the patient
  • •Medical contraindication for TENS

Arms & Interventions

TENS Eco2

Active Comparator

TENS Eco2 is the classical device in patients with chronic neuropathic pain

Intervention: TENS (Procedure)

actiTENS

Experimental

ActiTENS is a new TENS device, that seems less cotraining.

Intervention: TENS (Procedure)

Outcomes

Primary Outcomes

Disconfort of using TENS (Electrical Nerve Stimulation Therapy) Eco2 versus actiTENS

Time Frame: day 35 after patient inclusion

Discomfort evaluation will be determined by using VAS (Visual Analogue Scale)

Disconfort of using TENS (Electrical Nerve Stimulation Therapy) Eco2 versus actiTENS

Time Frame: day7 after patient inclusion

Discomfort evaluation will be determined by using VAS (Visual Analogue Scale)

Secondary Outcomes

  • length of TENS daily use(day 35 after patient inclusion)
  • length of TENS daily use(day7 after patient inclusion)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials